Increasing the precision of gene editing in vitro, ex vivo, and in vivo

被引:8
|
作者
Mueller, Katherine [1 ,2 ]
Carlson-Stevermer, Jared [1 ,2 ]
Saha, Krishanu [1 ,2 ]
机构
[1] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA
[2] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA
基金
美国国家科学基金会;
关键词
Genome editing; Gene therapy; Cell therapy; CRISPR-Cas9; Precision medicine; Regenerative Medicine;
D O I
10.1016/j.cobme.2018.08.006
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
New gene editing tools like CRISPR-Cas9 enable precision genome engineering within cell lines, primary cells, and model organisms, with some formulations now entering the clinic. "Precision" applies to various aspects of gene editing, and can be tailored for each application. Here we review recent advances in four types of precision in gene editing: 1) increased DNA cutting precision (e.g., on-target:off-target nuclease specificity), 2) increased on-target knock-in of sequence variants and transgenes (e.g., increased homology-directed repair), 3) increased transcriptional control of edited genes, and 4) increased specificity in delivery to a specific cell or tissue. Design of next-generation gene and cell therapies will likely exploit a combination of these advances.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 50 条
  • [41] In vitro and ex vivo models of adipocytes
    Dufau, Jeremy
    Shen, Joanne X.
    Couchet, Morgane
    Barbosa, Thais De Castro
    Mejhert, Niklas
    Massier, Lucas
    Griseti, Elena
    Mouisel, Etienne
    Amri, Ez-Zoubir
    Lauschke, Volker M.
    Ryden, Mikael
    Langin, Dominique
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2021, 320 (05): : C822 - C841
  • [42] Therapeutic Gene Editing of HSCs Ex Vivo without in Vitro Culture Avoids Genotoxicity, Simplifies Procedures, and Preserves Efficiency and Stemness
    Zeng, Jing
    My Anh Nguyen
    Ciuculescu, Marioara-Felicia
    Mintzer, Esther
    Liu, Pengpeng
    Lin, Linda Yingqi
    Rosanwo, Tolulope O.
    Verma, Archana
    Neri, Nola
    Maitland, Stacy A.
    Richter, Alden
    Justus, David G.
    Clement, Kendell
    Brendel, Christian
    Pinello, Luca
    Manis, John P.
    Armant, Myriam
    Wolfe, Scot A.
    Bauer, Daniel E.
    BLOOD, 2022, 140 : 10671 - 10672
  • [43] Extension of the crRNA enhances Cpf1 gene editing in vitro and in vivo
    Park, Hyo Min
    Liu, Hui
    Wu, Joann
    Chong, Anthony
    Mackley, Vanessa
    Fellmann, Christof
    Rao, Anirudh
    Jiang, Fuguo
    Chu, Hunghao
    Murthy, Niren
    Lee, Kunwoo
    NATURE COMMUNICATIONS, 2018, 9
  • [44] New Approaches towards ex vivo and in vivo gene therapy
    Hauser, H
    Spitzer, D
    Verhoeyen, E
    Unsinger, J
    Wirth, D
    CELLS TISSUES ORGANS, 2000, 167 (2-3) : 75 - 80
  • [45] In vivo and ex vivo regulation of bacterial virulence gene expression
    Cotter, PA
    Miller, JF
    CURRENT OPINION IN MICROBIOLOGY, 1998, 1 (01) : 17 - 26
  • [46] Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art
    Consiglieri, Giulia
    Bernardo, Maria Ester
    Brunetti-Pierri, Nicola
    Aiuti, Alessandro
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 36 (04) : 865 - 878
  • [47] Ex vivo and in vivo gene therapies for lysosomal storage diseases
    Ohashi, Toya
    JOURNAL OF GENE MEDICINE, 2006, 8 (12): : 1441 - 1442
  • [48] Extension of the crRNA enhances Cpf1 gene editing in vitro and in vivo
    Hyo Min Park
    Hui Liu
    Joann Wu
    Anthony Chong
    Vanessa Mackley
    Christof Fellmann
    Anirudh Rao
    Fuguo Jiang
    Hunghao Chu
    Niren Murthy
    Kunwoo Lee
    Nature Communications, 9
  • [49] Inhibition of HSV-1 replication in vitro and in vivo by a gene editing strategy
    Bellizzi, Anna
    Wollebo, Hassen S.
    Sariyer, Ilker K.
    Sariyer, Rahsan
    Jensen, Liselotte E.
    Huerta, Alvaro Torres
    Gordon, Jennifer
    Khalili, Kamel
    JOURNAL OF NEUROVIROLOGY, 2019, 25 (SUPPL 1) : S3 - S4
  • [50] Ex vivo gene transfer for gene therapy
    Gunzburg, WH
    GENE DELIVERY SYSTEMS: A STATE-OF-THE-ART REVIEW, 1996, : 53 - 57